NT-proBNP: what your result means.

A heart-stress marker released when the heart is under strain or overloaded. NT-proBNP is measured by blood test as part of the Cardiovascular panel in the HodieLabs Health Blueprint.

Why NT-proBNP matters

Sensitive marker of myocardial wall stress. Can detect cardiac dysfunction before symptoms appear.

Associated risks when out of range: Early cardiac strain. Heart failure risk. Atrial fibrillation risk. Cardiovascular mortality.

What the clinical evidence shows

The evidence base behind how the HodieLabs Evidence-Based Clinical Library interprets NT-proBNP, from randomised trials, prospective cohorts and genetic (Mendelian randomisation) studies. Full citations in the reference list below.

• Natriuretic Peptides Studies Collaboration (Lancet Diabetes & Endocrinology 2016): in ~95,000 participants without cardiovascular disease, NT-proBNP strongly predicted future coronary disease, stroke and heart failure. Cardiac wall stress is quantifiable years before symptoms.

Evidence-based reference ranges

The HodieLabs Evidence-Based Clinical Library interprets NT-proBNP against published clinical authority standards, never arbitrary "optimal" ranges. Measured in pg/mL:

Band	Range (pg/mL)
Optimal	<125 pg/mL
Borderline	125–300 pg/mL
High	>300 pg/mL
Very high	>900 pg/mL

Clinical interpretation

• Sensitive marker of myocardial wall stress.
• Can detect cardiac dysfunction before symptoms appear.
• Interpret alongside age, renal function and clinical context.

What improves it: the evidence-based levers

• Blood pressure optimisation
• Aerobic fitness improvement
• Weight optimisation
• Cardiology review if persistently elevated

Recommended testing frequency: Annual, as part of a comprehensive panel. Single markers are always interpreted in context.

How NT-proBNP testing works at HodieLabs

NT-proBNP is measured in every Health Blueprint at our Melbourne Preventative Health & Longevity Clinic, interpreted by a doctor against the guideline-cited ranges above and tracked over time through your HodieLabs membership.

References

1. Natriuretic Peptides Studies Collaboration. Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis. Lancet Diabetes Endocrinol. 2016;4:840–849.

This page is general information from the HodieLabs Evidence-Based Clinical Library, not medical advice. Speak with your GP about what testing and care is appropriate for you.